2-Hydroxy-9-(3-fluorophenyl)-3-undecylacridine-1,4-dione

ID: ALA5291351

Chembl Id: CHEMBL5291351

Max Phase: Preclinical

Molecular Formula: C30H32FNO3

Molecular Weight: 473.59

Names and Identifiers

Canonical SMILES:  CCCCCCCCCCCC1=C(O)C(=O)c2c(nc3ccccc3c2-c2cccc(F)c2)C1=O

Standard InChI:  InChI=1S/C30H32FNO3/c1-2-3-4-5-6-7-8-9-10-17-23-28(33)27-26(30(35)29(23)34)25(20-14-13-15-21(31)19-20)22-16-11-12-18-24(22)32-27/h11-16,18-19,34H,2-10,17H2,1H3

Standard InChI Key:  JNVUCKOHQHYMFE-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA5291351

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 473.59

Molecular Weight (Monoisotopic): 473.2366

AlogP: 8.15

#Rotatable Bonds: 11

Polar Surface Area: 67.26

Molecular Species: ACID

HBA: 4

HBD: 1

#RO5 Violations: 1

HBA (Lipinski): 4

HBD (Lipinski): 1

#RO5 Violations (Lipinski): 1

CX Acidic pKa: 5.40

CX Basic pKa: 1.37

CX LogP: 8.15

CX LogD: 6.16

Aromatic Rings: 3

Heavy Atoms: 35

QED Weighted: 0.29

Np Likeness Score: 0.17

References

1. Martín-Acosta P, Cuadrado I, González-Cofrade L, Pestano R, Hortelano S, de Las Heras B, Estévez-Braun A..  (2023)  Synthesis of Quinoline and Dihydroquinoline Embelin Derivatives as Cardioprotective Agents.,  86  (2.0): [PMID:36749898] [10.1021/acs.jnatprod.2c00924]

Source

Source(1):

• Scientific Literature